Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety"

被引：0
|
作者：
Yamamoto, Hiroyasu [1 ]
Nobori, Kiyoshi [2 ]
Matsuda, Yoshimi [2 ]
Hayashi, Yasuhiro [3 ]
Hayasaki, Takanori [3 ]
Akizawa, Tadao [4 ]
机构：
[1] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Tokyo, Japan
[2] Bayer Yakuhin Ltd, Res & Dev Japan, Osaka, Japan
[3] Bayer Yakuhin Ltd, Med Affairs & Pharmacovigilance, Osaka, Japan
[4] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2022年 / 52卷 / 12期
关键词：
D O I：
10.1159/000520156
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：977 / 978
页数：2
相关论文
共 50 条
  • [31] HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy?
    Gaete, Diana
    Rodriguez, Diego
    Watts, Deepika
    Sormendi, Sundary
    Chavakis, Triantafyllos
    Wielockx, Ben
    CANCERS, 2021, 13 (05) : 1 - 18
  • [32] Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis
    Chen, Dinghua
    Niu, Yue
    Liu, Fei
    Yang, Yue
    Wang, Xue
    Li, Ping
    Chen, Xiangmei
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Direct interaction of Pin1 with HIF-prolyl hydroxylase 2: Implications for breast cancer cell growth and survival
    Quispe, Yanymee Nimesia Guillen
    Kim, Su-Jung
    Saeidi, Soma
    Choi, Gyo-Jin
    Chelakkot, Chaithanya
    Zhou, Tianchi
    Bang, Sang-Beom
    Kim, Tae-Won
    Shin, Young-Kee
    Surh, Young-Joon
    CANCER RESEARCH, 2024, 84 (06)
  • [34] HIF-prolyl hydroxylase 2 silencing using siRNA delivered by MRI-visible nanoparticles improves therapy efficacy of transplanted EPCs for ischemic stroke
    Wang, Congxiao
    Lin, Gan
    Luan, Ying
    Ding, Jie
    Li, Pei-cheng
    Zhao, Zhen
    Qian, Cheng
    Liu, Gang
    Ju, Shenghong
    Teng, Gao-Jun
    BIOMATERIALS, 2019, 197 : 229 - 243
  • [35] Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change
    Pektas, Serap
    Knapp, Michael J.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2013, 126 : 55 - 60
  • [36] HIF-prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques
    Hsieh, Matthew M.
    Linde, N. Seth
    Wynter, Aisha
    Metzger, Mark
    Wong, Carol
    Langsetmo, Ingrid
    Lin, Al
    Smith, Reginald
    Rodgers, Griffin R.
    Donahue, Robert E.
    Klaus, Stephen J.
    Tisdale, John F.
    BLOOD, 2007, 110 (06) : 2140 - 2147
  • [37] Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: Implication in manganese-induced pulmonary inflammation
    Han, Jeongoh
    Lee, Jong-Suk
    Choi, Daekyu
    Lee, Youna
    Hong, Sungchae
    Choi, Jungyun
    Han, Songyi
    Ko, Yujin
    Kim, Jung-Ae
    Kim, Young Mi
    Jung, Yunjin
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (03) : 261 - 267
  • [38] HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
    Poloznikov, Andrey A.
    Nersisyan, Stepan A.
    Hushpulian, Dmitry M.
    Kazakov, Eliot H.
    Tonevitsky, Alexander G.
    Kazakov, Sergey, V
    Vechorko, Valery, I
    Nikulin, Sergey, V
    Makarova, Julia A.
    Gazaryan, Irina G.
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [39] Crystallographic and Selectivity Studies on the Approved HIF Prolyl Hydroxylase Inhibitors Desidustat and Enarodustat
    Corner, Thomas P.
    Salah, Eidarus
    Tumber, Anthony
    Kaur, Samanpreet
    Nakashima, Yu
    Allen, Mark D.
    Schnaubelt, Lara I.
    Fiorini, Giorgia
    Brewitz, Lennart
    Schofield, Christopher J.
    CHEMMEDCHEM, 2024, 19 (24)
  • [40] Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
    Kambara, Takahiro
    Shibata, Rei
    Sakamoto, Yuusuke
    Sakaguchi, Teruhiro
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    BMC RESEARCH NOTES, 2024, 17 (01)
12345